Market Tracker

07/22 5:16pm ET

Amarin Corporation PLC (NASDAQ:AMRN)

2.35
Delayed Data
As of Jul 22
 +0.02 / +0.86%
Today’s Change
1.24
Today|||52-Week Range
2.59
+24.34%
Year-to-Date
3 Risky Biotech Stocks That Could Make You Rich
Jul 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.33
Today’s open2.33
Day’s range2.31 - 2.38
Volume306,334
Average volume (3 months)987,291
Market cap$430.3M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-159.93%
Earnings growth (this year)+6.25%
Earnings growth (next 5 years)+207.00%
Revenue growth (last year)+51.17%
P/E ratioNM
Price/Sales4.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...-0.08-1.37%
FLXNFlexion Therapeutics...+0.27+1.63%
AMRIAlbany Molecular Res...-0.14-0.97%
ARWRArrowhead Pharmaceut...+0.07+1.25%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$81.6M
Annual profit (last year)-$148.8M
Net profit margin-182.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
Senior VP, Chief Financial &
Accounting Officer
Michael W. Kalb
Corporate headquarters
Dublin, Dublin

Forecasts